SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-068880
Filing Date
2020-03-10
Accepted
2020-03-10 16:46:25
Documents
5
Effectiveness Date
2020-03-10

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ON FORM S-8 d141259ds8.htm S-8 53395
2 EX-5.1 d141259dex51.htm EX-5.1 12308
3 EX-23.1 d141259dex231.htm EX-23.1 1659
4 GRAPHIC g141259dsp09.jpg GRAPHIC 3399
5 GRAPHIC g141259dsp09a.jpg GRAPHIC 2434
  Complete submission text file 0001193125-20-068880.txt   76740
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-237058 | Film No.: 20702265
SIC: 2834 Pharmaceutical Preparations